UBI Pharma 대차 대조표 상태
재무 상태 기준 확인 4/6
UBI Pharma has a total shareholder equity of NT$1.2B and total debt of NT$92.5M, which brings its debt-to-equity ratio to 7.9%. Its total assets and total liabilities are NT$1.8B and NT$666.8M respectively. UBI Pharma's EBIT is NT$5.5M making its interest coverage ratio 0.9. It has cash and short-term investments of NT$340.3M.
주요 정보
7.9%
부채 비율
NT$92.46m
부채
| 이자 보상 비율 | 0.9x |
| 현금 | NT$340.30m |
| 주식 | NT$1.17b |
| 총 부채 | NT$666.84m |
| 총 자산 | NT$1.84b |
최근 재무 상태 업데이트
업데이트 없음
Recent updates
재무 상태 분석
단기부채: 6562's short term assets (NT$680.4M) exceed its short term liabilities (NT$218.7M).
장기 부채: 6562's short term assets (NT$680.4M) exceed its long term liabilities (NT$448.1M).
부채 대 자본 내역 및 분석
부채 수준: 6562 has more cash than its total debt.
부채 감소: 6562's debt to equity ratio has reduced from 85.7% to 7.9% over the past 5 years.
부채 범위: 6562's debt is not well covered by operating cash flow (7.5%).
이자 보장: 6562's interest payments on its debt are not well covered by EBIT (0.9x coverage).